Reply to Weiner (1989;161:1091-2).

PubWeight™: 1.38‹?› | Rank: Top 10%

🔗 View Article (PMID 2301512)

Published in Am J Obstet Gynecol on January 01, 1990

Authors

F Daffos

Articles citing this

Cordocentesis and immune thrombocytopenia--continued. Am J Obstet Gynecol (1990) 0.75

Articles cited by this

Thrombocytopenia and cordocentesis clarifications requested. Am J Obstet Gynecol (1989) 1.93

Articles by these authors

(truncated to the top 100)

Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment. J Pediatr (1989) 2.98

Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test on amniotic fluid. N Engl J Med (1994) 2.94

Prenatal diagnosis of congenital toxoplasmosis. Lancet (1985) 2.43

Prenatal diagnosis of congenital rubella. Lancet (1984) 2.31

Fetal platelet counts in thrombocytopenic pregnancy. Lancet (1990) 2.13

Antenatal thrombocytopenia in three patients with TAR (thrombocytopenia with absent radii) syndrome. Prenat Diagn (1993) 2.11

Magnetic resonance imaging in antenatal diagnosis of tuberous sclerosis. Lancet (1992) 2.09

Fetal blood sampling during pregnancy with use of a needle guided by ultrasound: a study of 606 consecutive cases. Am J Obstet Gynecol (1985) 1.94

A unique T-cell receptor complex expressed on human fetal lymphocytes displaying natural-killer-like activity. Nature (1986) 1.90

Failure of fetal karyotyping and diagnosis of complete Di George syndrome. Lancet (1991) 1.68

Prenatal diagnosis of fetal cytomegalovirus infection. Am J Obstet Gynecol (1991) 1.62

Serum insulin-like growth factors and insulin-like growth factor binding proteins in the human fetus. Relationships with growth in normal subjects and in subjects with intrauterine growth retardation. Pediatr Res (1991) 1.61

Fetal toxoplasmosis: ultrasonographic signs. Ultrasound Obstet Gynecol (1991) 1.42

Changes in alpha 1-acid glycoprotein serum concentrations and glycoforms in the developing human fetus. Clin Chim Acta (1991) 1.38

Prenatal and postnatal production of IgM and IgA antibodies to rubella virus studied by antibody capture immunoassay. J Infect Dis (1988) 1.12

Fetal blood sampling via the umbilical cord using a needle guided by ultrasound. Report of 66 cases. Prenat Diagn (1983) 1.09

Early prenatal diagnosis of congenital toxoplasmosis using amniotic fluid samples and tissue culture. Eur J Clin Microbiol Infect Dis (1988) 1.05

Rapid prenatal diagnosis of Down's syndrome with in-situ hybridisation of fluorescent DNA probes. Lancet (1986) 1.02

Diagnosis of Toxoplasma infection in the pregnant woman and the unborn child: current problems. Scand J Infect Dis Suppl (1992) 1.01

Fetal and neonatal alloimmune thrombocytopenia: current trends in diagnosis and therapy. Transfus Med (1992) 0.99

Perinatal-lethal Gaucher disease. Am J Med Genet A (2003) 0.98

Hematological values of 163 normal fetuses between 18 and 30 weeks of gestation. Pediatr Res (1986) 0.98

Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection. BJOG (2007) 0.95

Toxoplasmosis in pregnancy. Lancet (1994) 0.95

Developmental hematopoiesis in normal human fetal blood. Blood (1991) 0.94

Prenatal treatment of alloimmune thrombocytopenia. Lancet (1984) 0.94

[Infectious fetal diseases. Prevention, prenatal diagnosis, practical measures]. Presse Med (1991) 0.94

In utero treatment of toxoplasmic fetopathy with the combination pyrimethamine-sulfadiazine. Fetal Diagn Ther (1993) 0.93

Prenatal diagnosis of fetal varicella-zoster virus infection with polymerase chain reaction of amniotic fluid in 107 cases. Am J Obstet Gynecol (1997) 0.93

The assessment of fetal blood samples. Am J Obstet Gynecol (1988) 0.92

Placental transfer of vitamin K1 and its implications in fetal hemostasis. Thromb Haemost (1988) 0.91

The prognostic value of ultrasound abnormalities and biological parameters in blood of fetuses infected with cytomegalovirus. BJOG (2008) 0.89

Very early intracranial haemorrhage in alloimmune fetal thrombocytopenia. Lancet (1990) 0.89

A new procedure for fetal blood sampling in utero: preliminary results of fifty-three cases. Am J Obstet Gynecol (1983) 0.88

[Fetal toxoplasmosis. In utero treatment with pyrimethamine sulfamides]. Arch Fr Pediatr (1991) 0.88

Blood chemistry of normal human fetuses at midtrimester of pregnancy. Pediatr Res (1987) 0.88

Vitamin K dependent proteins in fetal hemostasis at mid trimester of pregnancy. Thromb Haemost (1985) 0.87

Management of alloimmune thrombocytopenia: antenatal diagnosis and in utero transfusion of maternal platelets. Blood (1988) 0.87

Haematological parameters of parvovirus B19 infection in 13 fetuses with hydrops foetalis. Br J Haematol (1999) 0.86

Toxoplasma gondii infection during pregnancy: T lymphocyte subpopulations in mothers and fetuses. Pediatr Infect Dis J (1990) 0.86

[Toxoplasmosis in pregnancy. Diagnosis and new therapeutic possibilities]. Presse Med (1993) 0.85

Determination of platelet antigens and glycoproteins in the human fetus. Blood (1986) 0.84

Presence of an acid-labile alpha-interferon in sera from fetuses and children with congenital rubella. J Clin Microbiol (1985) 0.84

Low molecular weight heparin (PK 10169) does not cross the placenta during the second trimester of pregnancy study by direct fetal blood sampling under ultrasound. Thromb Res (1984) 0.84

Fetal thrombocytopenia: a retrospective survey of 5,194 fetal blood samplings. Blood (1994) 0.84

First-trimester diagnosis of nuchal anomalies: significance and fetal outcome. Ultrasound Obstet Gynecol (1992) 0.84

Absence of transplacental passage of fragmin (Kabi) during the second and the third trimesters of pregnancy. Thromb Haemost (1992) 0.83

Physiology and management of intrauterine growth retardation: a biologic approach with fetal blood sampling. Am J Obstet Gynecol (1988) 0.83

[Fetomaternal therapeutic follow-up of spiramycin during pregnancy]. Arch Fr Pediatr (1988) 0.81

Prenatal diagnosis with biotinylated chromosome specific probes. Prenat Diagn (1988) 0.81

Fetal blood sampling during the third trimester of pregnancy. Br J Obstet Gynaecol (1984) 0.80

Assessment of fetal blood volume for computer-assisted management of in utero transfusion. Fetal Ther (1988) 0.80

Ocular toxoplasmosis in the fetus. Immunohistochemistry analysis and DNA amplification. Retina (1994) 0.80

Presence of gamma interferon in human acute and congenital toxoplasmosis. J Clin Microbiol (1990) 0.80

[Value of fetal blood collection in prenatal diagnosis, fetology and therapy in utero]. Ann Biol Clin (Paris) (1985) 0.79

Characterization of mononuclear cell subpopulations in normal fetal peripheral blood. Hum Immunol (1987) 0.79

Low molecular weight heparin (CY 216) does not cross the placenta during the third trimester of pregnancy. Thromb Haemost (1987) 0.79

T-cell subpopulations of fetuses infected by Toxoplasma gondii. Eur J Clin Microbiol Infect Dis (1989) 0.78

Gradual appearance of total IgM in fetal serum during the second trimester of pregnancy. Application to the prenatal diagnosis of fetal infections. Ann Biol Clin (Paris) (1984) 0.78

Fetal gammaglutamyl transferase activity: clinical implication in fetal medicine. Biol Neonate (1996) 0.78

Corticosteroid sulfates in fetus plasma. J Steroid Biochem (1989) 0.78

Prenatal diagnosis of congenital toxoplasmosis by PCR: extended experience. Prenat Diagn (1998) 0.77

Serum somatomedin-C and bioassayable growth-promoting activity (thymidine activity) in appropriate and small-for-gestational-age human newborns. Acta Endocrinol (Copenh) (1985) 0.77

Contribution of prenatal imaging to the anatomical assessment of fetal hydrocolpos. Ultrasound Obstet Gynecol (2007) 0.77

Management of fetal and neonatal alloimmune thrombocytopenia. Transfus Med Rev (1996) 0.77

Fetal blood sampling in twin pregnancies. Prenatal diagnosis and management of 19 cases. Fetal Ther (1987) 0.77

[Medical termination of pregnancy for fetal anomaly: the patient's point of view]. J Gynecol Obstet Biol Reprod (Paris) (2000) 0.77

High levels of circulating thrombomodulin in human foetuses and children. Thromb Haemost (1999) 0.76

[The passage of fluoride across the placenta. An intra-uterine study]. J Gynecol Obstet Biol Reprod (Paris) (1990) 0.76

Repeated fetal losses and the lupus anticoagulant. Ann Intern Med (1988) 0.76

[Fetal karyotyping of fetal blood obtained from the umbilical vein using ultrasound]. J Gynecol Obstet Biol Reprod (Paris) (1985) 0.76

Tumour-associated antigens in maternal and fetal blood. Prenat Diagn (1994) 0.76

Erythropoietic progenitor cells in human fetal blood. Nouv Rev Fr Hematol (1991) 0.76

Prenatal diagnosis of tuberous sclerosis. Use of magnetic resonance imaging and its implications for prognosis. Prenat Diagn (1994) 0.75

Persistent maternal viremia after varicella infection during pregnancy as a possible cause of false positive prenatal diagnosis of fetal infection on amniotic fluid. BJOG (2004) 0.75

[Prenatal detection of coagulation disorders and hemophilia]. Rev Prat (1987) 0.75

First-trimester fetal diagnosis of hemoglobinopathies and hemophilias by DNA analysis: a three years experience. Contrib Gynecol Obstet (1986) 0.75

Prenatal diagnosis of hemophilia by fetal blood sampling under ultrasound guidance. Haemostasis (1986) 0.75

Possibility of prenatal diagnosis of hereditary triose phosphate isomerase deficiency. Prenat Diagn (1986) 0.75

[Pulmonary scintigraphy in check-up and surveillance of oral contraception]. Contracept Fertil Sex (Paris) (1975) 0.75

[An update on the fetal circulation]. J Gynecol Obstet Biol Reprod (Paris) (2004) 0.75

Serum somatomedin C, bioassayable growth-promoting activity (thymidine activity), and transferrin in human fetuses: in utero study. Pediatr Res (1986) 0.75

[Letter: Hemorrhage of the fetus in its placenta. Compression of the umbilical cord during gemellary labor]. Nouv Presse Med (1975) 0.75

Allogeneic responses of human fetal (22- to 25-week) peripheral blood lymphocytes: preferential recruitment of cytotoxic effector cells with both CTL activity and NK-like function. Cell Immunol (1986) 0.75

Blood group antigens on fetal red cells obtained by umbilical vein puncture under ultrasound guidance: a rapid hemagglutination test to check for contamination with maternal blood. Pediatr Res (1986) 0.75

Prenatal diagnosis of a molecular variant of Glanzmann's thrombasthenia. Curr Stud Hematol Blood Transfus (1988) 0.75

[Foetal sampling techniques]. Gynecol Obstet Fertil (2003) 0.75

[Immunization against the ZWa (PLA1) platelet antigen: group at risk, prevention of complications. Apropos of 132 cases]. Pathol Biol (Paris) (1986) 0.75

[Prenatal diagnosis of hemophilia A during the first trimester of pregnancy]. Presse Med (1986) 0.75

Prenatal diagnosis of hereditary elliptocytosis with molecular defect of spectrin. Prenat Diagn (1987) 0.75

Antithrombin III (ATIII) and heparin cofactor II (HCII) in normal human fetuses (21st-27th week) Thromb Haemost (1986) 0.75

[Prenatal pharmacology of low molecular weight heparin and pentosan polysulfate]. J Mal Vasc (1987) 0.75

[Abnormal placental caryotype in severe intrauterine growth retardations (IUGR). Case report]. Gynecol Obstet Fertil (2007) 0.75

[Intrahepatic arteriovenous fistula. Prenatal diagnosis, physiopathological study and neonatal management]l. J Gynecol Obstet Biol Reprod (Paris) (1998) 0.75

In utero fetal sampling in neonatal alloimmune thrombocytopenia: justification and usefulness. Curr Stud Hematol Blood Transfus (1988) 0.75

Serum growth-promoting activity in normal and hypotrophic fetuses at midpregnancy. Pediatr Res (1987) 0.75

Absence of transplacental passage of pentosan polysulfate during mid trimester of pregnancy. Thromb Haemost (1986) 0.75

Perinatal management of fetal cardiac anomalies in a specialized obstetric-pediatrics center. Am J Perinatol (2001) 0.75

[Absence of transplacental passage of Fraxiparin (low molecular weight heparin) during the 3d trimester of pregnancy]. J Gynecol Obstet Biol Reprod (Paris) (1987) 0.75

Allo-immune thrombocytopenias, definition of a group at risk; a prospective study. Curr Stud Hematol Blood Transfus (1988) 0.75